pentobarbital will lower the level or effect of buprenorphine subdermal implant by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Watch Closely. Keep track of sufferers currently on buprenorphine subdermal implant who involve recently-initiated treatment with CYP3A4 inducer for symptoms and indicators of withdrawal.Warning sh